EPO and myocardial ischemia: Other in-vivo studies of cardiac ischemia in rat model indicated that EPO could have acute cardioprotective effect at 5000 IU/Kg with reduction in cardiomyocyte loss, infarct size and apoptosis, and also normalization of hemodynamic function (22-24).